Related by context. All words. (Click for frequent words.) 77 Acute Radiation Syndrome ARS 74 Protexia R 73 Protectan CBLB# 73 Radilex 72 Acute Radiation Syndrome 71 MAXY G# 71 CBLB# 71 Anthim 70 OncoVEX GM CSF 70 Valortim 69 SparVax TM 69 Valortim ® 69 Protexia ® 69 Valortim R 69 OncoVEX 69 Trofex 68 rPA anthrax vaccine 68 compound Protectan CBLB# 68 chemotherapy induced neutropenia 68 H#N# VLP vaccine 68 Ebola SNALP 68 MAGE A3 ASCI 68 AEOL # 67 MGd 67 OHR/AVR# 67 LC#m# 67 rBChE 67 HQK 67 Restanza 67 RiVax 67 Protexia 67 Altastaph 67 CCX# 67 ELACYT 67 ganetespib 66 PXD# 66 SparVax ™ 66 mertansine 66 trastuzumab DM1 T DM1 66 HCV protease inhibitors 66 Lenocta 66 CEQ# 66 Civacir 66 HuMax CD4 66 Onconase 66 bafetinib 66 ALN TTR# 66 depsipeptide 66 Azedra 66 DXL# 66 SNT MC# 66 Archexin 66 forodesine 66 oral prodrug 66 AEG# 66 nonclinical studies 66 drug ISA# 66 Homspera 66 Factor VIIa 66 preclinical efficacy 65 Neumune 65 Neuradiab 65 PROCHYMAL 65 pafuramidine 65 IMA# 65 MOZOBIL 65 TRO# 65 BioVant 65 BEXXAR 65 Tamibarotene 65 Fibrillex TM 65 ASONEP 65 elotuzumab 65 AVP #D# 65 CINTREDEKIN BESUDOTOX 65 OvaRex R 65 PEG SN# 65 MEK inhibitors 65 YONDELIS 65 trivalent influenza vaccine 65 JAK inhibitors 65 immune modulatory 65 Aviptadil 65 IMVAMUNE R 65 systemically administered 65 Cerashield 65 talactoferrin 65 Ceflatonin 65 CR# vcMMAE 65 Xanafide 65 attenuated smallpox vaccine 65 Voraxaze 65 BiTE antibody 65 IMVAMUNE ® 65 Triolex 64 Allovectin 7 R 64 rilonacept 64 HBV vaccine 64 FluCide 64 OvaRex ® MAb 64 CBLC# 64 Androxal TM 64 NovaBay Aganocide compounds 64 Sym# 64 torezolid phosphate 64 SparVax 64 favorable pharmacokinetic profile 64 HGS ETR1 64 Protectan 64 MAXY alpha 64 lomitapide 64 PhG alpha 1 64 amrubicin 64 XmAb# 64 phase IIa clinical 64 ARIKACE ™ 64 ISTODAX 64 riociguat 64 IRX 2 64 lucinactant 64 GTC recombinant human 64 PSMA ADC 64 Traficet EN 64 RiVax ™ 64 antigen sparing 64 Curaxin CBLC# 64 Aurexis 64 EndoTAG TM -1 64 Panzem R NCD 64 Zemiva TM 64 FOLOTYN ® 64 EP #R 64 faropenem 64 investigational monoclonal antibody 64 Phase IIb clinical trials 64 RiVax TM 64 Chemophase 64 HGS ETR2 64 RIGScan CR 64 Panzem R 64 demonstrated antitumor activity 64 NEUGENE 64 ENMD # 64 Cloretazine 64 HCD# [002] 64 HepaGam B 64 Octreolin 64 Amrubicin 64 TBC# 64 HspE7 64 GED aPC 64 radiation countermeasure 64 #D#C# 64 vosaroxin 64 Cinryze ™ 63 Vaxfectin 63 CCR5 mAb 63 biodefense countermeasure 63 ALN VSP 63 R#/MEM # 63 tanespimycin 63 Aplidin 63 raxibacumab 63 velafermin 63 Multimeric 63 candidate TNFerade biologic 63 JAK3 63 UPLYSO 63 GRNVAC1 63 Bezielle 63 PDE4 inhibitor 63 non nucleoside HCV 63 liposomal formulation 63 Fx #A 63 Phase #b/#a clinical 63 Telatinib 63 alkylating agent 63 MyVax R 63 TPI ASM8 63 Ampligen ® 63 Prochymal 63 CYT# potent vascular disrupting 63 Imvamune 63 TransVax ™ 63 HGS ETR1 mapatumumab 63 OMP #M# 63 INCB# [001] 63 Shigamabs ® 63 Thiovir 63 daptomycin 63 PLX cells 63 ALN TTR 63 cilengitide 63 iSONEP 63 PROSTVAC TM 63 proteasome inhibitor 63 CMV vaccine 63 Tarvacin TM 63 Amplimexon 63 EOquin TM 63 mapatumumab 63 BrachySil 63 Reolysin 63 viral kinetics 63 Solazed TM 63 anti EGFR antibody 63 Cethromycin 63 omega interferon 63 GAMMAGARD 63 NP2 Enkephalin 63 investigational smallpox vaccine 63 GLP toxicology studies 63 Azedra TM 63 telaprevir VX 63 Virulizin ® 63 TYZEKA 63 Ampligen R 63 Prodarsan ® 63 TKM ApoB 63 huC# DM4 63 teplizumab 63 masitinib 63 ATryn ® 63 MyVax ® 63 personalized immunotherapy 63 urocortin 2 63 selective modulator 63 MGN# 63 Exherin TM 63 Virulizin R 63 pharmacodynamic PD 63 TKM PLK1 63 investigational humanized monoclonal antibody 63 SinuNase TM 63 PLK1 SNALP 63 Mipomersen 63 axitinib 62 eTag assays 62 HuCAL antibodies 62 Bicifadine 62 synthetic retinoid 62 JAK2 inhibitor 62 RhuDex ® 62 ONCONASE 62 AQ4N 62 TOCOSOL Paclitaxel 62 Triapine R 62 Immunotherapeutic 62 Perifosine 62 bortezomib Velcade 62 potent cytotoxic 62 CRMD# 62 targeted radiotherapeutic 62 refractory acute myeloid 62 APOPTONE 62 REOLYSIN ® 62 Allovectin 7 ® 62 galiximab 62 Combidex 62 MEK inhibitor 62 vidofludimus 62 pradefovir 62 CD# CEA 62 ALN RSV# 62 Onalta 62 nanoviricides 62 orBec 62 ROTARIX 62 Proxinium TM 62 Cloretazine ® 62 therapeutic monoclonal antibody 62 Phase Ib study 62 TKM Ebola 62 FluINsure 62 dacetuzumab 62 PANVAC VF 62 Allovectin 7 62 OMAPRO 62 lenalidomide Revlimid R 62 Chimigen TM 62 Voraxaze ™ 62 OMNARIS HFA 62 defensin mimetic antibiotic 62 SAR# [004] 62 UVIDEM 62 histone deacetylase inhibitor 62 Aerosurf 62 pomalidomide 62 PNP inhibitor 62 cellular immunotherapy 62 AMPK activators 62 G#DT 62 eniluracil 62 PRT# 62 ALN PCS 62 Maribavir 62 oncological indications 62 PEGPH# 62 Bendavia 62 Hemopurifier ® 62 NeuroSTAT ® 62 Cytolin ® 62 alvespimycin 62 elacytarabine 62 DCVax ® 62 IMVAMUNE TM 62 targeting CD# 62 VitiGam 62 Dacogen injection 62 FavId 62 rxRNA 62 ANAVEX #-# [001] 62 samalizumab 62 dose cohort 62 RGB # 62 telomerase inhibitor 62 DAVANAT R 62 Degarelix 62 PRTX 62 Phase IIB 62 incyclinide 62 nalbuphine ER 62 monoclonal antibody conjugated 62 metaglidasen 62 Bioral 62 Squalamine 62 cancer immunotherapies 62 anticancer agent 62 Interferon alpha 62 APTIVUS r 62 Intravenous CP 62 immunomodulator 62 voreloxin 62 PROVENGE sipuleucel T 62 Cloretazine R VNP#M 62 BLA filing 62 injectable formulations 62 Urocidin 62 canakinumab 62 candidate CRLX# 62 CA4P 62 interferon gamma 1b 62 ruxolitinib 62 Fodosine 62 Plenaxis R 62 CTAP# Capsules 62 PrevOnco ™ 62 neratinib 62 immunotherapeutic vaccine 62 erlotinib Tarceva ® 62 ketolide antibiotic 62 Fabry Disease 62 JAK inhibitor 62 investigational hepatitis B 62 Bortezomib 62 iroxanadine 62 HuLuc# 62 Personalized Immunotherapy 62 Behcet uveitis 62 PGL# 62 Cytolin R 62 atacicept 62 acetonide FA 62 inhibitor RG# 62 TransVax TM 62 immunotoxins 61 VivaGel TM 61 LE DT 61 IL# PE#QQR 61 Genasense ® oblimersen 61 ATL# [001] 61 omecamtiv mecarbil 61 sodium stibogluconate 61 rFVIIIFc 61 NPC 1C 61 cleavable linker 61 BrachySil TM 61 antiangiogenic agents 61 #ME# 61 OXi# 61 Proellex TM 61 Prodarsan 61 elvucitabine 61 CCR5 antagonist 61 preclinical toxicology 61 Amigal 61 mitogen activated ERK kinase 61 somatostatin analogue 61 preclinically 61 ROTATEQ 61 MGCD# [001] 61 SIRT1 activators 61 nanoviricide drug 61 anti CD# antibody 61 Urocidin TM 61 therapeutic regimens 61 Trofex TM 61 Alferon N 61 Apoptone 61 sapacitabine 61 Orphan Drug designations 61 ATL# [002] 61 relapsed MM 61 ZADAXIN 61 Golimumab 61 Interferon Beta 61 small molecule defensin 61 trabectedin 61 TELINTRA 61 INTERCEPT platelets 61 ORENCIA R 61 ThermoDox R 61 OncoVex 61 Abiraterone acetate 61 Tarceva TM 61 Granulocyte Colony Stimulating Factor 61 molecular chaperone regulation 61 phase IIb trial 61 celgosivir 61 recombinant factor VIIa 61 anticoagulant reversing agent 61 LibiGel ® 61 oncolytic virus therapy 61 Alzhemed TM 61 HCV protease inhibitor 61 Valortim TM 61 orally administered inhibitor 61 Cellegesic 61 Arimoclomol 61 VIR# 61 Myocet 61 adenoviral vectors 61 investigational therapies 61 SNALP technology 61 THALOMID 61 Linjeta TM 61 Zolinza 61 XL# XL# 61 tezampanel NGX# 61 Solazed 61 Menerba 61 novel therapeutic antibodies 61 MYCAMINE 61 ospemifene 61 HuMax EGFr 61 Phase 2a clinical trials 61 Liprotamase 61 tafamidis 61 BARACLUDE R 61 therapeutic monoclonal antibodies 61 CORT # 61 Viramidine 61 Cetrorelix 61 GAP #B# 61 pralatrexate 61 non nucleoside 61 ATL/TV# 61 CRLX# 61 Insegia 61 Fast Track Status 61 CGEN # 61 ATryn R 61 cMET 61 Panzem 61 Fast Track designations 61 BioNumerik 61 Thalomid ® 61 aerosolized AAT 61 serum antibody 61 Psoraxine R 61 NEUGENE antisense 61 IND submission 61 CD# monoclonal antibody 61 immunomodulatory 61 IAP inhibitor 61 Surfaxin LS 61 Pralatrexate 61 intradermal injection 61 LEP ETU 61 talabostat 61 phase IIb clinical 61 butyrylcholinesterase 61 immune modulating 61 vemurafenib 61 Azixa 61 SomatoKine 61 Tarmogen 61 velafermin belinostat 61 MT#/MEDI-# 61 OMP #R# 61 PEGylated interferon 61 ApoB SNALP 61 Tyrima 61 pexiganan 61 anti CD3 antibody 61 Maxy G# 61 DPX Survivac 61 Multiferon R 61 XOMA 3AB 61 MAXY VII 61 TRISENOX ® 61 PDX pralatrexate 61 Plicera 61 Chrysalin 61 tamibarotene 61 Cloretazine R 61 Genasense ® 61 Ramoplanin 61 lesinurad 61 neuraminidase inhibitor 61 Shigamabs R 61 MYDICAR ® 61 ACZ# 61 StaphVAX R 61 valopicitabine 61 EndoTAG TM 61 ZADAXIN ® 61 Dalbavancin 61 SERMs 61 fosbretabulin 61 GVAX ® 61 Symadex 61 neuroprotective properties 61 refractory prostate cancer 61 inhaled AAT 61 HDL Selective Delipidation 61 Alpharadin 61 Anidulafungin 61 Onalta ™ 61 Radezolid 61 GFT# 61 PI3K/Akt pathway inhibitor 61 apricitabine 61 antiangiogenic activity 61 HepeX B 61 L BLP# 61 dexanabinol 61 BrachySil ™ 61 blood clot dissolver 61 Poly ICLC 61 Androxal ® 61 GeoVax vaccine 61 systemic immunosuppressive drugs 61 tolevamer 61 inactivated influenza vaccine 61 MEK inhibitor RDEA# 61 Medical Countermeasure 61 bardoxolone 61 compound AEOL # 61 romidepsin 61 Blinatumomab 61 oncolytic virus 61 PKC# 61 ganaxolone 61 MVA BN R 61 Octreotide 61 rNAPc2 61 Hollis Eden 61 subcutaneous formulation 61 XYNTHA 61 Prodarsan R 61 TRISENOX 61 LEUKINE 61 teduglutide 61 Protectans 61 FDA Orphan Drug 61 preclinical 61 CANCIDAS 61 gemifloxacin 61 bioscavenger 61 nucleotide analog 61 cariprazine 61 Tectin TM 61 histamine dihydrochloride 60 immune modulator 60 imetelstat 60 Pafuramidine 60 Zn DTPA 60 Elotuzumab 60 Diamyd ® 60 budesonide foam 60 HEPLISAV TM 60 Phase Ib II 60 nucleotide analogs 60 CLORETAZINE TM VNP#M 60 ONCONASE R 60 Marqibo TM 60 Tarvacin 60 anticancer therapy 60 MEK Inhibitor 60 GRN# 60 Poly ICR 60 Phase #/#a trial 60 preclinical studies 60 TNFerade 60 ZFP Therapeutic 60 Exelixis compounds 60 rhThrombin 60 sulodexide 60 TREANDA 60 trastuzumab Herceptin R 60 HepaGam B TM 60 eprotirome 60 oral antiviral 60 Stedivaze 60 Allovectin 7 r 60 trastuzumab DM1 60 docetaxel Taxotere ® 60 Phase IIIb clinical 60 Neugene 60 esophageal candidiasis 60 Preclinical studies suggest 60 immunotherapeutic 60 ImmunoVEX HSV2 60 LNP formulations 60 prophylactic vaccines 60 IMC #B 60 Zerenex 60 microsphere therapy 60 Phase Ib clinical 60 AP# [003] 60 vismodegib 60 nicotinic alpha 7 60 Alvesco R 60 volociximab 60 recurrent glioblastoma multiforme 60 triphendiol 60 oral talactoferrin 60 epigenetic therapies 60 Cx# [002] 60 Atiprimod 60 recombinant interferon 60 Spiegelmer ® 60 Icatibant 60 receiving immunosuppressive therapy 60 Phase 2b Clinical Trial 60 ThermoDox ® 60 TKB# 60 Pyridorin 60 GLPG# 60 Phase 2a trial 60 Tß4 60 Mitoxantrone 60 ABthrax 60 antifibrotic 60 cidofovir 60 pharmacokinetic interactions 60 REPLAGAL 60 rFIXFc 60 Guanilib 60 Cethrin 60 Specifid 60 busulfan 60 VitiGam TM 60 NeuroVax TM 60 sodium thiosulfate STS 60 Anturol TM 60 postexposure 60 cytoprotective 60 GVAX Pancreas Vaccine 60 TOLAMBA 60 HuMax TAC 60 cintredekin besudotox 60 TACI Ig 60 PREOS 60 Alocrest 60 Epothilones 60 Amphotericin B 60 reslizumab 60 BioThrax R 60 recombinant subunit vaccine 60 intranasal delivery 60 Darinaparsin 60 RNAi Therapeutic 60 Tavocept 60 CCR5 inhibitors 60 Soliris TM eculizumab 60 TG# [003] 60 PentaStaph 60 pharmacodynamic markers 60 E1 INT TM 60 refractory CLL 60 obatoclax 60 pharmacokinetic PK study 60 vivo validation 60 AzaSite Plus 60 AVN# [001] 60 XL# XL# XL# XL# 60 PS# [001] 60 liposomal doxorubicin 60 SynCon 60 Aurora kinase inhibitor 60 HCV polymerase 60 novel antiviral therapeutics 60 humanized antibodies 60 clevidipine 60 thymalfasin 60 EVIZON TM 60 acadesine 60 novel VDA molecule 60 ddRNAi 60 prGCD 60 anticancer compound 60 pharmacokinetic studies 60 Phenoptin 60 cannabinor 60 EFAPROXYN 60 Natalizumab 60 HuMax CD# 60 Revimmune 60 TELCYTA 60 Anticalins 60 Sphingomab 60 etanercept Enbrel 60 Ganite ® 60 JVRS 60 CCR9 antagonist 60 AEGR 60 CoFactor 60 TRAIL receptor antibodies 60 Pentacel vaccine 60 Pimavanserin 60 PEG Interferon lambda 60 otelixizumab 60 rPA vaccine candidate 60 hereditary deficiency 60 indibulin 60 dose escalation clinical 60 registrational 60 siRNA therapeutic 60 Enzyme Replacement Therapy 60 Epanova 60 forodesine hydrochloride 60 bovine thrombin 60 DCVax R Brain 60 Sulonex TM 60 GRNCM1 60 Methylnaltrexone 60 midstage trials 60 kidney urologic 60 cysteamine bitartrate 60 EGRIFTA TM 60 BiovaxID TM 60 CDDO Im 60 ReN# 60 RLY# 60 cytostatic 60 APTIVUS ritonavir 60 Vascugel 60 Curaxin 60 anti CD3 60 Saforis 60 LB# [003] 60 anti CD# antibodies 60 receptor tyrosine kinase inhibitor 60 CTCE 60 Hedgehog Pathway Inhibitor 60 Aflibercept 60 TORISEL 60 INT# [002] 60 rHuPH# 60 Cethrin R 60 Japanese Encephalitis Vaccine 60 NurOwn 60 thrombin inhibitor 60 Veronate 60 EDEMA3 trial 60 calcineurin inhibitors 60 siRNA therapeutics 60 YONDELIS R 60 Vilazodone 60 pharmacological chaperone 60 aflibercept VEGF Trap 60 ularitide 60 LHRH agonists 60 rhITF 60 successfully commercialize Iluvien 60 metastatic RCC 60 factor G CSF 60 Hepatocellular Carcinoma HCC 60 Litx 60 tolerability profiles 60 DermaVir Patch 60 Orphan Status 60 Cintredekin Besudotox 60 TLR9 agonist 60 radiotherapeutic 60 Toraymyxin TM 60 CIMZIA TM 60 Vandetanib 60 DEB# 60 anti leukemic 60 pDNA vaccine 60 Orphan Drug status 60 CXB# 60 Restanza TM 60 BRAF inhibitors 60 synthetic siRNA 60 Alinia 60 Tovaxin 60 tremelimumab 60 recurrent glioma 60 Epratuzumab 60 Campath ® 60 TLR9 agonists 60 SURFAXIN 60 Thrombin 60 influenza VLP vaccine 60 herpetic keratitis 60 relapsed ALL 60 RenaZorb TM 60 Afatinib 60 superficial bladder cancer 60 drug GAP #B# 60 IV Busulfex 60 Dacogen decitabine 60 lumiliximab 60 Aryplase 60 Leukine ® 60 ATG Fresenius S 60 Bioral Amphotericin B 60 zanolimumab 60 tiapamil 60 VLP vaccine 60 pain palliation 60 XP# XP# 60 HSP# inhibitor 60 novel anticancer 59 opioid bowel dysfunction 59 ZOLINZA 59 antitumoral 59 radiation sensitizer 59 Fibrin Pad 59 Aptivus ® 59 Soliris eculizumab 59 DermaVir 59 KNS # 59 replicon 59 StemEx R 59 Oragens TM 59 recombinant polyclonal antibody 59 Q#IR 59 ritonavir boosted danoprevir 59 NTDDS 59 Zalypsis 59 calcitonin 59 please visit www.advaxis.com 59 romidepsin novel 59 BNC# 59 Viprinex 59 immunomodulatory properties 59 sorafenib tablets 59 KIACTA ™ 59 inecalcitol 59 bioterrorist weapon 59 Cardio Vascu Grow 59 encapsulates siRNAs 59 INCB# [002] 59 evaluating tivozanib 59 allogeneic HSCT 59 selective androgen receptor modulator 59 invasive aspergillosis 59 JAK1 59 ridaforolimus 59 Aflunov 59 Kosan dependence 59 quinolone 59 Stimuvax R 59 cediranib 59 Arikace 59 allogeneic stem cell 59 dalbavancin 59 BAL# [002] 59 Cytolin 59 HGS# 59 ZFP Therapeutics 59 PSN# [002] 59 Anavex #-# 59 rALLy trial 59 Vaxfectin TM 59 antiangiogenic therapy 59 Romidepsin 59 DiabeCell ® 59 C1 INH 59 efaproxiral 59 adalimumab Humira 59 Apaziquone 59 Dacetuzumab 59 Urocortin 2 59 vapreotide acetate 59 IMP# 59 isoform selective 59 InterfeRx 59 lintuzumab 59 CD# antibody [001] 59 thalidomide Thalomid 59 ADP receptor antagonist 59 isavuconazole 59 dacarbazine chemotherapy 59 next generation URAT1 59 KRN# 59 Diabetic Macular Edema 59 ongoing Phase 1b 59 maximally tolerated dose 59 TNF antagonist 59 sorafenib Nexavar 59 Hsp# Inhibitor 59 CMV disease 59 Phase IIb III 59 menadione 59 trastuzumab Herceptin ® 59 Metastatic Melanoma 59 Dasatinib 59 Plasmin 59 uric acid lowering 59 either acutely decompensated 59 Prosaptide 59 SCIg 59 L MTP PE 59 Teflaro 59 Nanobodies ® 59 DAVANAT ® 59 Cerashield ™ 59 #I TM# 59 SCIB1 59 DepoVax 59 Phase #/#a 59 teratogenic effects 59 NEBIDO 59 IMiDs ® 59 NXL# 59 adult mesenchymal stem 59 Iluvien TM 59 BEXXAR Therapeutic Regimen 59 TLK# 59 vilazodone 59 radiolabeled TM# 59 FOLOTYN 59 H#N# antigen 59 adecatumumab 59 SILENOR TM 59 SinuNase 59 oncolytic viruses 59 LHRH antagonist 59 Imprime PGG 59 ulimorelin 59 PHX# 59 nitazoxanide 59 huN# DM1 59 ostarine 59 Zevalin consolidation 59 Noxafil 59 Manja Bouman CEO 59 Zysolin TM 59 Anticalins ® 59 Reports Preclinical Data 59 CIMZIA ™ 59 Hepatitis C Virus HCV 59 TNF alpha antagonist 59 immunomodulation 59 oxypurinol 59 novel peptides 59 severe hypersensitivity reactions 59 autologous cellular immunotherapy 59 relapsed multiple myeloma 59 nanopharmaceutical 59 blinatumomab 59 tezampanel 59 Rotarix R 59 SPRYCEL ® 59 VAPRISOL 59 null responder 59 Excellarate 59 Pemetrexed 59 novel peptide 59 alefacept 59 neuroendocrine cancers 59 AKT inhibitor 59 Entereg R 59 AeroLEF TM 59 Lisofylline LSF 59 hoFH 59 methylnaltrexone 59 live attenuated vaccines 59 StemEx 59 GGF2 59 custirsen 59 virus HCV protease inhibitor 59 Gliadel Wafer 59 Vacc 4x 59 ALK inhibitor 59 PCK# 59 Increlex R 59 brostallicin 59 Treatment IND 59 DOR# 59 HE# [002] 59 humanized anti 59 Pazopanib